WELL Q4 normalized FFO rises 28.3% to USD 1.45 per diluted share

Reuters
02/11
WELL Q4 normalized FFO rises 28.3% to USD 1.45 per diluted share

Welltower Inc. reported its financial results for the fourth quarter and full year 2025. In the fourth quarter (Q4), the company posted net income attributable to common stockholders of USD 0.14 per diluted share. Quarterly normalized funds from operations (FFO) attributable to common stockholders reached USD 1.45 per diluted share, reflecting an increase of 28.3%. For the full year 2025, Welltower Inc. reported net income attributable to common stockholders of USD 1.39 per diluted share. Annual normalized FFO attributable to common stockholders was USD 5.29 per diluted share, an increase of 22.5%. Total portfolio year-over-year same store net operating income (SSNOI) grew by 15.0% in Q4, supported by a 20.4% increase in the Seniors Housing Operating $(SHO)$ portfolio. The SHO portfolio's organic same store revenue rose by 9.6% year-over-year in the fourth quarter, driven by an average occupancy growth of 400 basis points and a 4.7% increase in Revenue Per Occupied Room (RevPOR). The SSNOI margin for the SHO portfolio expanded by 270 basis points year-over-year. During the period, Welltower Inc. expanded its 10 Year Executive Continuity and Alignment Program to include seven Executive Vice Presidents, aligning compensation further with long-term performance. The program now covers 12 senior leaders who receive a reduced base salary and a single, predominantly performance-based, long-term equity incentive award.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Welltower Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL85058) on February 10, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10